IDH1 and central nervous system cancer: Like IDH-mutant glioma, G34R/V glioma was thought to be driven by epigenomic reprogramming [48], as G34R/V promotes repressive trimethylation of histone 3 lysine 27, also seen in IDH-mutant glioma cells, to block neuronal differentiation [47].